MANUEL MOSQUERA: Open Payments
NPI 1356368245 · JACKSON HEIGHTS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 21 payments from 6 companies in 2025. Trend: 2023 $293 · 2024 $641 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $126 |
| E.R. Squibb & Sons, L.L.C. | 3 | $77 |
| Lundbeck LLC | 3 | $75 |
| Teva Pharmaceuticals USA, Inc. | 2 | $68 |
| Janssen Pharmaceuticals, Inc | 1 | $40 |
Products named: ARISTADA, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, UZEDY, AUSTEDO XR, LYBALVI.
Industry payments across NY — which companies pay providers there.
